Let’s reconsider your research – InnoSer contract breeding services
COVID-19 restrictions brought extra challenges to breeding and maintaining colonies within academic facilities. If you are looking for a service provider resilient to today’s vulnerable environment, InnoSer is here to support you. Let’s put your research back on track...
InnoSer participates in the AACR annual meeting 2020
InnoSer is proud to announce its participation in the annual meeting of the American Association for Cancer Research. As committed contributors to the preclinical oncology field, we look forward to interacting with the community throughout the event. We make this...
InnoSer welcomes Pascal Simoëns as its new Business Development Manager
As of June 2020, Pascal Simoëns has joined InnoSer in the role of business development manager (BDM). Pascal will be translating InnoSer’s products and services towards the fields of potential and existing client portfolios. By doing so, he will be creating a...
InnoSer joins the Eurostars funded project ‘LEMONAID’
LEMONAID takes on the challenge of developing a new drug against Diffuse Large B-Cell Lymphoma (DLBCL) tumors to ultimately reduce drug resistance and relapse potential for patients. InnoSer supports this ambition by its expertise in combined in-vitro and in-vivo...
Recent Comments